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     Coagulase-negative staphylococci (CNS) are a main cause of nosocomial infection. The main purpose of 
this study was to determination of frequency of CNS isolates in in hospitalized patients and their susceptibility 
pattern to antimicrobial agents. During 11 month study, 65 CNS clinical isolates were recovered from 
hospitalized patients in different wards of hospital. In vitro susceptibility of isolates to 12 antimicrobial agents 
Penicillin; Ampicilin; Cephalothin; Cefoxitin; linezolid; Nitofurantoin; Erythromycin; Norfloxacin; 
Gentamicin; Vancomycin; Chloramphenicol and Oxacillin was performed by Kirby-Bauer’s Disk diffusion 
method according to Clinical and Laboratory Standards Institute (CLSI) criteria. Out of 1875 samples of 
hospitalized patients 65(3.47%) patients were infected with CNS. Twenty one (32.3 %) were isolated from the 
urine samples, 17(26.1%) from sputum, 15(23.1%) from pus samples, 8(12.3 %) from ear swabs, 3(4.7%) from 
fluid and 1(1.5%) from blood sample. All of CNS isolates were sensitive to nitrofurantoin. The rates of 
resistance to the majority of antibiotics tested varied between 4.5% and 100 %. The rate of resistance to beta 
lactam antibiotics, Chloramphenicol, erythromycin, gentamycin was high (more than 70%). The most of 
isolates remained susceptible to linezolid, and nitofurantoin. All of isolates were susceptible to vancomycin. 
Multi-drug resistant CNS with reduced susceptibility to linezolid and nitrofurantoin are emerging pathogens of 
clinical concern. Monitoring of antibiotic resistance with attention to multi-resistant profile and aware to 
practitioners in the field is necessary.  
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INTRODUCTION 
     Nosocomial infections are important public 
health problems in developing countries as well as 
in developed countries. Nosocomial or hospital-
acquired infections are usually defined as 
infections that are identified at least 48-72 hours 
following admission to hospital and health care 
facility [1]. The most frequent types of nosocomial 
infections are bloodstream infection (BSI), urinary 
tract infection (UTI), pneumonia and surgical-
wound infection [2]. 
Coagulase-negative staphylococci (CNS) are a 
group of micro-organisms that known as normal 
biota of human skin and mucous membranes. CNS 
are consisting of 39 Species and 16 Species of 
them are known to cause infection in human. Since 
the 1970s, CNS is recognized as important 
etiologic agents of a wide variety of human 
nosocomial infections. They account for 9% of 
nosocomial infections [4]. 
The two most frequently encountered CNS species 
in clinical samples are Staphlococcus epidermidis 
and Staphlococcus saprophyticus. Overall, S. 
epidermidis is the predominant agent in 
nosocomial infection, bacteremia, intravascular 
catheter-related infections, endocarditis, central 
nervous system shunt infections, urinary tract 
infections, ophthalmologic infections, dialysis-
related infections and surgical wounds while S. 
saprophyticus is more associated with urinary tract 
 




infections in young females. Therefore, CNS 
isolates have received more attention recently as a 
cause for above mentioned infections [4,5]. The 
Distinguishing between true pathogen and 
contaminating isolates is very difficult and remains 
a main problem. Accurate species level 
identification of CNS isolates is expensive and 
time consuming. According to past researches, 
identification to species level is not necessary for 
good patient management and treatment [6]. 
Nowadays the role of CNS as potentially agent in 
nosocomial blood stream infections and UTI has 
been recognized. CNS isolates account for 
approximately 30% of all nosocomial blood stream 
infections. Among CNS isolates Staphlococcus 
epidermidis is most frequently associated with 
blood stream infection [7]. The use of indwelling 
medical devices such as central and peripheral 
venous catheters, artificial heart valves, valvular 
prostheses, pace-makers and orthopaedic 
prostheses in patients is the one of main 
predisposing agents S.epidermidis bacteremia[8]. 
UTI is one of the most frequent types of 
nosocomial infections and probably affects about 
one-half of all people during their lifetimes. Many 
of clinicians are commonly encountered with UTIs 
in developing countries. UTI refer to the existence 
of microbial pathogens in the urinary tract and 
defined as the growth of a single pathogen of >10
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colony-forming units per milliliter from properly 
collected mid-stream urine specimens [9,10]. 
UTIs are often caused by different bacteria. 
Bacterial agents are responsible for a spectrum of 
UTI that can be ranged from mild irritative voiding 
to bacteremia, sepsis and death. UTIs can often be 
asymptomatic or asymptomatic [11]. The major 
causatives of UTIs are Escherichia coli and other 
Enterobacteriacae. Although relative frequency of 
the pathogens varies depending upon age, sex, 
catheterization and hospitalization but in 
complicated urinary tract infections and 
hospitalized patients, Gram-negative rods 
(Pseudomonas spp) and gram positive cocci 
(coagulase negative Staphylococci, Staphylococcus 
aureus, Streptococcus group B, Enterococci) are 
comparatively more common [12].  
Recently, in all over the world, resistance to 
antibiotics among CNS isolates has been reported. 
The infections associated with CNS requiring 
antimicrobial therapy. Inappropriate use of 
antimicrobial agents in order to treatment of 
patients recently has led to the spread of 
antimicrobial resistance among CNS isolates. On 
the other hand, widespread resistance among CNS 
isolates is major problem for the empirical 
treatment of nosocomial infections [11,12]. 
During the past decade, CNS isolates exhibited a 
remarkable ability to rapidly develop antibiotic 
resistance. Area-specific monitoring studies in 
order to detection of antimicrobial resistance 
patterns, effective treatment and decrease mortality 
rates is necessary [12]. 
Considering lack of information about 
antimicrobial resistance profiles of CNS clinical 
isolates and increasing infections, the object of this 
study was to investigate the frequency of CNS 
isolates in hospitalized patients and their 
susceptibility pattern to commonly used 
antimicrobial agents.  
 
MATERIALS AND METHODS 
Bacterial isolates 
    The present descriptive study was performed on 
cases who were hospitalized in different wards of 
hospital. A total of 65 clinically significant CNS 
isolates collected from different clinical samples 
for a period of 11 months from during Jun 2012 to 
May 2013. CNSs were isolated from sputum, 
blood, pus, urine and body fluide samples. Isolates 
were diagnosed as true pathogen when isolated in 
pure culture from infected sites. 
UTI refer to the existence of microbial pathogens 
in the urinary tract and defined as the growth of a 
single pathogen of >10
5
 colony-forming units per 
milliliter (CFU/ml) from properly collected mid-
stream urine specimens [13]. All the cases had 
history of nosocomial infection and clinical 
examination was conducted by physician to 
exclude community-acquired infections.  
The plates were incubated in aerobic conditions at 
37◦C for 24–48 hours. Negative cultures were 
maintained in incubator up to 2 days.  
Identification of specimens was performed by 
Gram staining, catalase, manitol fermentation and 
coagulase tests and other conventional biochemical 
tests. Coagulase test was done both slide and tube 
methods [14, 15]. Samples confirmed as a CNS 
isolates were stored in Tryptic Soy Broth (TSB; 
Merck, Germany) containing 20% glycerol at -
70°C and were subjected to further investigation. 
 




Antimicrobial susceptibility testing 
    To evaluate antimicrobial susceptibility of 
isolates Kirby-Bauer’s Disk diffusion method was 
done according Clinical Laboratory and Standards 
Institute (CLSI; formerly National Committee for 
Clinical Laboratory Standards) criteria [16]. The 
following antimicrobial agents were used in this 
study: Penicillin; Ampicilin; Cephalothin; 
Cefoxitin; linezolid; Nitofurantoin; Erythromycin; 
Norfloxacin; Gentamicin; Vancomycin; 
Chloramphenicol and Oxacillin. 
Antibiotic disks used in this research were supplied 
by MAST Laboratories Ltd (Bootle, Merseyside, 
UK). Briefly, the bacterial suspension obtained 
from overnight cultures. The turbidity of each 
bacterial suspension was adjusted equivalent to a 
no. 0.5 McFarland standard and then inoculated on 
Mueller-Hinton agar (Oxoid, UK). Diameter of 
inhibition zones was measured after incubation at 
35ºC for 18-24 hours, and data were reported as 
susceptible, intermediate, and resistant. 
Staphylococcus aureus ATCC 25923 was used as 
reference strains for susceptibility testing. Data 
were analyzed using SPSS version 13 software. 
 
RESULTS 
     In this study, a total of 1875 samples of 
hospitalized patients were screened during a period 
of 11 months, 65(3.47%) patients were infected 
with CNS of which there were 36 (55.4%) females 
and 29 (44.6%) males. The age range of the 
patients was from 3 to 72 years. Among 65 isolates 
of CNS, 21 (32.3 %) were isolated from the urine 
samples, 17(26.1%) from sputum, 15(23.1%) from 
pus samples, 8(12.3 %) from ear swabs, 3(4.7%) 
from fluid and 1(1.5%) from blood sample. All 
isolates of CNS were negative for free and tube 
coagulase. 
Occurrence of infection with CNS was highest in 
the age group 21-45 year (60%) and the lowest in 
the age less than or equal to 20 years (3.1%). In 
males, majority of the CNS 18(27.6) found in the 
age group 21-45 years and in females, 21(32.4) in 
found in age group 25-32 years. Frequency of 
CNS in different age groups is shown in Table1. 
The patients were distributed in 6 hospital 
department. Twenty-four isolates (36.9%) of CNS 
was obtained from internal medicine, 14 isolates 
(21.6%) from infectious ward, 10 isolates (15.4%) 
from surgical ward, 8 isolates(12.3%) from 
gastroenterology, 6 isolates (9.2%) from Intensive 
Care Unit and 3 isolates (4.6%) from Pediatric 
ward. 
No significant difference was found between 
isolated bacteria and age of the patients. The 
profile of isolated bacterial showed wide different 
level of resistance for tested antibiotics (Data are 
shown in Table 2). Antibiotic susceptibility 
testing of the isolates showed maximum 
resistance to penicillin (95.4%) and ampicillin 
(89.2%) followed by gentamycin (86.2%), 
cefoxitin(84.7%), cefalotin(83%), 
erythromycin(76.9%),  chloramphenicol (73.8%), 
norfloxacin (69.2%), oxacillin(58.5%), 
linezolid(23.1%) and nitofurantoin(3.1%). All of 
isolates were sensitive to vancomycin. Multidrug-
resistant (MDR) was defined as resistance to at 
least three or more antibiotics (17,18). Of 65 
isolates tested 51(47.8%) were MDR. Frequencies 
of MDR to four, five, six or more antibiotics were 
19(37.2%), 15(29.4%), 12(23.5%) and 5(9.8%). 
MDR strains to three or more tested antibiotics 
were isolates from hospitalized patients in internal 
medicine, surgery, infectious, ICU and 
gastroenterology wards respectively. The 
predominant resistance profile among our isolates 
were included resistance to 4 antibiotics 
(penicillin, Ampicilin, Gentamicin ad cefalotin), 5 
antibiotices (penicillin, Ampicilin, Gentamicin, 
cefoxitin and chloramphenicol) and 6 antibiotices 
(penicillin, Ampicilin, Gentamicin, cefoxitin, 
chloramphenicol and erythromycin) which were 
common among 14(27.4%), 11 (21.6%) and 
7(13.7%) isolates. 
 












Male 1(1.55) 18(27.6) 6(9.3) 4(6.1) 29(44.6) 
Female 1(1.55) 21(32.4) 8(12.3) 6(9.2) 36(55.4) 
Total 2(3.1) 39(60) 14(21.6) 10(15.3) 65(100) 
 





Table 2. Frequency and antimicrobial susceptibility pattern of 65 CNS isolates to 12 antimicrobial agents 
Antibiotics Susceptible(%) Intermediate(%) Resistance(%) Total (%) 
Penicillin 2(3.1) 1(1.5) 62(95.4) 65(100) 
ampicillin 5(7.7) 2(3.1) 58(89.2) 65(100) 
gentamycin 7(10.7) 2(3.1) 56(86.2) 65(100) 
cefoxitin 7(10.7) 3(4.6) 55(84.7) 65(100) 
cefalotin 10(15.5) 1(1.5) 54(83) 65(100) 
erythromycin 12(18.5) 3(4.6) 50(76.9) 65(100) 
Chloramphenicol 10(15.5) 7(10.7) 48(73.8) 65(100) 
norfloxacin 16(24.6) 4(6.2) 45(69.2) 65(100) 
oxacillin 22(33.8) 5(7.7) 38(58.5) 65(100) 
linezolid 48(73.8) 2(3.1) 15(23.1) 65(100) 
nitofurantoin 63(96.9) 0(0) 2(3.1) 65(100) 
vancomycin 65(100) 0(0) 0(0) 65(100) 
 
DISCUSSION 
    Nosocomial infection is a global problem that 
affects both developed and developing countries. 
Recent studies have revealed the importance of 
CNS as one of the causes of nosocomial or health-
care related infections. Many of nosocomial 
infections are associated with microorganisms 
that are resistant to antibiotics and can easily 
spread by hospital environment and personnel. 
Monitoring of antimicrobial susceptibility can aid 
to clinicians for prescript appropriate antibiotics 
and prevent the development of drug resistance 
[15]. Effective treatment of patients with UTI and 
blood stream infections associated with CNS 
commonly relays on the identification of the type 
of organisms and the selection of an effective 
antibiotic agent to the organism in question. The 
pattern of antimicrobial resistance of CNS 
producing infection varies in different regions and 
especially different wards [16].  
In this study, the frequency of CNS isolated from 
hospitalized patient in different wards was 
65(3.47%) of which there were 36 (55.4%) 
females and 29 (44.6%) males. Among different 
clinical samples, CNS isolates were mainly 
isolated from 21 (32.3 %) urine samples in 
female. 
This result is consistent with the results of recent 
studies in India [17,18]. In a study done by Vaez 
et al in 2012, CNS was mostly isolated from 
blood cultures that are in contrary with our study 
(Iran5). In another study done by Banerjee et al, 
72 of 150 strains of CNS (60%) were isolated 
from blood samples, 36(24%) from pus samples, 
15(10%) from urinary catheter tip and 12(8%) 
from the urine samples [19]. 
High frequency of UTI associated with CNS in 
our study, may be attributed to contamination 
during sampling, anatomy and microflora in 
genitourinary system, host factors, hygiene 
practices and healthcare practices. The sex 
distribution of patients in our study mainly was 
female (55.4%) between 21 to 45 years. This 
result is similar to those reported from many other 
researchers [16]. 
In this study, we investigated the frequency and 
antimicrobial susceptibility patterns of CNS 
isolated from hospitalized patients in Tehran, 
Iran. 
This study revealed that all of CNS isolates were 
fully sensitive to vancomycin. Our finding about 
vancomycin is in accordance with studies done in 
India 2012, Spain 2002, England 2004, Asia-
Pacific region 2007, USA 2007 and Turkey 
2007[20-24] 
In our study, the highest resistance rate of the 
CNS was against penicillin (95.4%) followed by 
ampicillin (89.2%) followed by gentamycin 
(86.2%), 
cefoxitin(84.7%),cefalotin(83%),erythromycin(76
.9%), chloramphenicol (73.8%), norfloxacin 
(69.2%) and oxacillin(58.5%). This study 
correlates with a study by Asangi et al, where the 
antibiotic susceptibility testing showed maximum 
resistance to penicillin and ampicillin with 85%-
95%. In study Sader et al. 85%-95% of CNS were 
resistance to ampicillin and penicillin. High 
resistances to these antibiotics have been reported 
by several researchers [17]. Resistance to 
 




Resistance to ampicillin, penicillin, cefoxitin and 
cefalotin among our isolates may be related to 
improper usage of this antibiotic for treatment of 
other infections, increase use of other beta lactam 
antibiotics in hospital and acquisition of resistant 
during hospitalization. 
Resistances to erytromycin have been reported 
differently by several researchers. In Spain, 
resistance to erythromycin increased 
progressively in CNS from 41% in 1986 to 63% 
in 2002 (20). Asangi et al. showed high level of 
resistance to erythromycin among CNS isolates 
[17]. In two surveillance studies, performed in 
2006, in US and Europe CNS isolates had 
increased resistance rate to erythromycin [25].   
The possible reasons of high resistant rate to 
erythromycin may be related to use of 
erythromycin in treatment of disease caused by 
CNS and common infections, increase exposure 
of this isolates to new macrolide, efflux of the 
drug and ribosomal methylation. Cross resistance 
between clindamycin and macrolides is well 
described by several investigators. 
The resistance rate to linzolide was 23.1%in our 
study, which was higher than Spain, US and 
Turkey, Englans, Australia and Irland [20-26]. 
The resistance rate to gentamicin in among CNS 
isolates was higher than other studies [27,28]. The 
data from our investigation exhibited that 
ampicillin, penicillin, cefoxitin, cefalotin, 
gentamicin, norfloxacin and erythromycin had not 
good activity against CNS isolates.  
Surprisingly, in our study the resistance to 
linezolid in comparison with other studies done 
by several researcher was relatively high [4, 
24,29, 30] which the reason for resistance to these 
antibiotics could be mediated by their widespread 
use in the hospital and the community.  
A high incidence of MDR strains was found in 
internal medicine and infectious wards in our 
study. It could be attributable to high usage of 
antimicrobials agents in internal medicine and 
Infectious wards. It should not be ignored that 
MDR strains of CNS can serve as a reservoir of 
resistance genes and can spread to the other 
microorganisms. Therefore, in order to prevent 
further spread of multi-drug resistant CNS, the 
use of antibiotics should be monitored and 
implementation of infection control. In the other 
hand, continued use of antibiotic for treatment of 
infections associated with CNS isolates should be 
supported by monitoring of antimicrobial 
susceptibility to prevent the spread of resistant 
isolates and also eliminate the use of antibiotics 
for a prolonged period. 
Although resistant to linzolid and nitrofurantoin 
has seen among our isolates but it seems that them 
can be effective drugs for treatment of infections 
associated with CNS isolates. According to our 
findings, ampicillin, penicillin, cefoxitin, 
cefalotin, gentamicin, norfloxacin and 
erythromycin are not effective drugs for treatment 
of infections associated with CNS. Progressive 
increase in resistant to these antibiotics and 
multiple resistances in present study, may be 
related to increased usage of these antibiotics for 
treatment and also ability of strains in acquisition 
of resistance genes to other organisms of different 
species. Our investigation also exhibited that use 
of linzolid in order to decrease spread of 
resistance gene among CNS isolates must be 
revised. 
In conclusion, high level of resistance among 
CNS isolates limits the use of antimicrobial 
agents for therapy and also the spread of MDR 
isolates is threat for hospitalized patients. 
Continuous Surveillance for multidrug-resistant 
strains is necessary to prevent the further spread 
of resistant isolates. 
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